SAM Request (Amendment 1 -)

SAM.gov Notice Details

Required Notice Details for Posting Subcontracting Opportunities to SAM.gov The following informational items are needed for posting notices to SAM.gov: UPDATE – Amendment 01 (H27-1001) – 10/16/26
Notice ID: (Solicitation H27-1001)
1. Request for Proposal in support of the National Cancer Institute (NCI), Multiple Award IDIQ Construction Contract 2. Title: “NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”
3. NAICS: 236220 – Commercial and Institutional Building Construction

4. Offer Due Date:

• Proposals are due by November 20, 2026, at 3:00 p.m. EST 5. Description - National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements:

SOLCITATION H27-1001

Description of Work: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR).
To obtain a copy of solicitation H27-1001 and other information concerning this opportunity, please refer to: https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/construction-idiqcontract or
contact Matthew Hull (Contracts Manager) at [email protected] For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations
Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime

P.O. Box B, Frederick, MD 21702-1201 • 301-846-1000
A subsidiary of

Rev. Feb 2024

SAM.gov Notice Details
Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.

The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed)